AI Summary
Thinking
Thinking
We reviewed 3 live results for adc conjugation and narrowed them down to the 3 options that look most worth comparing first.
The options are Custom Conjugation, Oligonucleotide Conjugation Kit and Antikörper-Wirkstoff-Konjugat (ADC) Services.
Source: Columbia Biosciences
Description
Columbia Biosciences provides custom conjugation and reagent development services tailored for antibody and protein labeling across research, critical reagent, OEM product lines, and FDA-cleared diagnostics. Capabilities include labeling immunoconjugates, proteins, peptides, nucleic acids, and small molecules with fluorophores, enzymes, and biotin. The service features rapid 10-to-14-day turnaround, scale-up from milligrams to grams, diverse conjugation chemistries such as amine, thiol, and bioorthogonal labeling, and full quality control including Certificate of Analysis documentation under ISO 13485 standards.
Best for
researchers, pharmaceutical companies, antibody labeling and protein conjugation
Rate this product
Source: RayBiotech
Description
The RayBio Oligonucleotide Conjugation Kit by RayBiotech provides a fast and efficient method to generate oligo-antibody conjugates for oligo-delivery and detection applications. Requiring less than 20 minutes of hands-on time, it achieves over 90% conjugation efficiency across varying oligo-to-antibody ratios. Designed for 100 micrograms of purified antibody per reaction, the kit includes positive control reagents and is available in 2-reaction and 10-reaction package sizes with 1 to 2 business days estimated lead time.
Best for
Researchers, Laboratory scientists and Generating oligo-antibody conjugates for detection or delivery tools
Rate this product
Source: ProteoGenix
Description
ProteoGenix bietet spezialisierte Antikörper-Wirkstoff-Konjugat (ADC) Services für die Entwicklung von Therapeutika vom Proof-of-Concept bis zu klinikfähigem Material. Das Angebot umfasst chemische und enzymatische Konjugationstechnologien, präzise Drug-to-Antibody Ratio (DAR)-Kontrolle mit über 90 % Homogenität sowie eine breite Auswahl an Linkern und Payloads. Unterstützt werden diverse Antikörperformate von VHH bis IgG, ergänzt durch umfassende Charakterisierungsanalysen wie DAR-Bestimmung, HPLC und Massenspektrometrie in einem Entwicklungszeitrahmen von drei bis sechs Wochen.
Best for
Biotech-Unternehmen, Pharmazeutische Forscher, Therapeutika-Entwicklung and Proof-of-Concept-Studien
Rate this product
| Compare | #1Custom Conjugation | #2Oligonucleotide Conjugation Kit | #3Antikörper-Wirkstoff-Konjugat (ADC) Services |
|---|---|---|---|
| Source | Columbia Biosciences | RayBiotech | ProteoGenix |
| Description | Columbia Biosciences provides custom conjugation and reagent development services tailored for antibody and protein labeling across research, critical reagent, OEM product lines, and FDA-cleared diagnostics. Capabilities include labeling immunoconjugates, proteins, peptides, nucleic acids, and small molecules with fluorophores, enzymes, and biotin. The service features rapid 10-to-14-day turnaround, scale-up from milligrams to grams, diverse conjugation chemistries such as amine, thiol, and bioorthogonal labeling, and full quality control including Certificate of Analysis documentation under ISO 13485 standards. | The RayBio Oligonucleotide Conjugation Kit by RayBiotech provides a fast and efficient method to generate oligo-antibody conjugates for oligo-delivery and detection applications. Requiring less than 20 minutes of hands-on time, it achieves over 90% conjugation efficiency across varying oligo-to-antibody ratios. Designed for 100 micrograms of purified antibody per reaction, the kit includes positive control reagents and is available in 2-reaction and 10-reaction package sizes with 1 to 2 business days estimated lead time. | ProteoGenix bietet spezialisierte Antikörper-Wirkstoff-Konjugat (ADC) Services für die Entwicklung von Therapeutika vom Proof-of-Concept bis zu klinikfähigem Material. Das Angebot umfasst chemische und enzymatische Konjugationstechnologien, präzise Drug-to-Antibody Ratio (DAR)-Kontrolle mit über 90 % Homogenität sowie eine breite Auswahl an Linkern und Payloads. Unterstützt werden diverse Antikörperformate von VHH bis IgG, ergänzt durch umfassende Charakterisierungsanalysen wie DAR-Bestimmung, HPLC und Massenspektrometrie in einem Entwicklungszeitrahmen von drei bis sechs Wochen. |
| Best for | researchers, pharmaceutical companies, antibody labeling and protein conjugation | Researchers, Laboratory scientists and Generating oligo-antibody conjugates for detection or delivery tools | Biotech-Unternehmen, Pharmazeutische Forscher, Therapeutika-Entwicklung and Proof-of-Concept-Studien |
| Action | Columbia Biosciences | RayBiotech | ProteoGenix |
| Rate this product |
"Custom Conjugation from Columbia Biosciences."
Note: TopFind AI compiles product and service information for general comparison purposes only.